The estimated Net Worth of Mark Kawakami is at least $5.67 ezer dollars as of 1 August 2024. Mark Kawakami owns over 700 units of Arcadia Biosciences Inc stock worth over $5,666 and over the last few years Mark sold RKDA stock worth over $0.
Mark has made over 1 trades of the Arcadia Biosciences Inc stock since 2024, according to the Form 4 filled with the SEC. Most recently Mark bought 700 units of RKDA stock worth $1,442 on 1 August 2024.
The largest trade Mark's ever made was buying 700 units of Arcadia Biosciences Inc stock on 1 August 2024 worth over $1,442. On average, Mark trades about 350 units every 0 days since 2024. As of 1 August 2024 Mark still owns at least 1,981 units of Arcadia Biosciences Inc stock.
You can see the complete history of Mark Kawakami stock trades at the bottom of the page.
Mark's mailing address filed with the SEC is C/O ARCADIA BIOSCIENCES, INC., 5950 SHERRY LANE, SUITE 215, DALLAS, TX, 75225.
Over the last 9 years, insiders at Arcadia Biosciences Inc have traded over $35,492 worth of Arcadia Biosciences Inc stock and bought 2,813,834 units worth $22,335,794 . The most active insiders traders include Terri Csperling Peter V Mor..., Darby E Shupp és Albert D. Bolles. On average, Arcadia Biosciences Inc executives and independent directors trade stock every 49 days with the average trade being worth of $147,899. The most recent stock trade was executed by Mark Kawakami on 1 August 2024, trading 700 units of RKDA stock currently worth $1,442.
arcadia biosciences (nasdaq: rkda) develops and markets high-value food ingredients and nutritional oils that help meet consumer demand for a healthier diet. arcadia’s goodwheat™ branded ingredients deliver health benefits to consumers and enable consumer packaged goods companies to differentiate their brands in the marketplace. the company’s portfolio of agricultural traits are being developed to enable farmers around the world to be more productive and minimize the impact of agriculture on the environment. for more information visit www.arcadiabio.com.
Arcadia Biosciences Inc executives and other stock owners filed with the SEC include: